Search by Drug Name or NDC
NDC 43598-0169-58 Enalaprilat 2.5 mg/2mL Details
Enalaprilat 2.5 mg/2mL
Enalaprilat is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Dr. Reddys Laboratories Inc. The primary component is ENALAPRILAT.
Product Information
| NDC | 43598-0169 |
|---|---|
| Product ID | 43598-169_4a20e779-1cb3-d987-ab48-c2da16611d15 |
| Associated GPIs | |
| GCN Sequence Number | 000383 |
| GCN Sequence Number Description | enalaprilat dihydrate VIAL 1.25 MG/ML INTRAVEN |
| HIC3 | A4D |
| HIC3 Description | ANTIHYPERTENSIVES, ACE INHIBITORS |
| GCN | 47580 |
| HICL Sequence Number | 013237 |
| HICL Sequence Number Description | ENALAPRILAT DIHYDRATE |
| Brand/Generic | Generic |
| Proprietary Name | Enalaprilat |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | enalaprilat |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/2mL |
| Substance Name | ENALAPRILAT |
| Labeler Name | Dr. Reddys Laboratories Inc |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075578 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43598-0169-58 (43598016958)
| NDC Package Code | 43598-169-58 |
|---|---|
| Billing NDC | 43598016958 |
| Package | 10 VIAL in 1 CARTON (43598-169-58) / 2 mL in 1 VIAL (43598-169-11) |
| Marketing Start Date | 2023-06-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |